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A B S T R A C T
This study aimed to evaluate the eﬀects of Cinnamaldehyde, Carvacrol, and honey either alone or in combi-
nations on the expression of exoS and ampC genes in multidrug-resistant (MDR) P. aeruginosa isolates.
Thirty-ﬁve P. aeruginosa isolates were recovered from burn wound infections of patients admitted to the burn
ward of Besat hospital of Hamadan, Iran, during 2018. Antibiotic susceptibility testing was performed using the
Kirby-Bauer disk diﬀusion method to identify MDR isolates. The antibacterial eﬀects of Cinnamaldehyde,
Carvacrol, and honey either alone or in combinations with each other were compared to Imipenem (as the
control group) using the broth dilution method. The expressions of exoS and ampC genes were determined in
bacteria treated with sub-minimum inhibitory concentration (MIC) of the ternary combination of
Cinnamaldehyde, Carvacrol, and honey by Real-Time-PCR. The data were analyzed using SPSS software ap-
plying student t-test, Kruskal-Wallis, and Mann-Whitney U tests. The P-value less than 0.05 was considered as
statistically signiﬁcant. The average MICs of Cinnamaldehyde, Carvacrol, and honey were 0.82–0.01, 0.01–0.6,
and 62.5–250 μg/mL, respectively. The average MIC of the mentioned compounds was 430 times lower than that
of Imipenem. A synergistic eﬀect was detected between these drugs against 70% of the isolates. At sub-MIC
concentration, the triple combination of Cinnamaldehyde, Carvacrol, and honey reduced the expressions of exoS
and ampC genes by 6.12 and 2.85 folds, respectively. The combination of Cinnamaldehyde, Carvacrol, and honey
showed a higher antibacterial eﬀect than Imipenem. However, it needs conﬁrmation with more isolates.
1. Introduction
Pseudomonas aeruginosa is a Gram-negative bacillus naturally found
in the digestive tract and skin. P. aeruginosa is considered as the second
and third most common cause of opportunistic burn and nosocomial
infections respectively. Patients with burn wounds are particularly
susceptible to the development of treatment-resistant infections [1].
Sepsis caused by P. aeruginosa is a serious consequence of burn infec-
tions associated with a high mortality rate [2,3].
Although antibiotics are ﬁrst-line therapies against bacterial infec-
tions, the prevalence of multi-drug resistant (MDR) strains is increasing
around the world. Improper antibiotic usage is considered as the main
contributor to the emergence of MDR strains [4,5]. Infections caused by
antibiotic-resistant bacteria are associated with higher health costs and
mortality rates, as well as longer hospital stay and treatment course [6].
Despite the development of many new generation anti-pseudomonas
agents, P. aeruginosa infections are generally resistant to therapy. Due to
the multi-drug resistance nature of P. aeruginosa infections, these are
currently treated using combinations of beta-lactams, ﬂuoroquinolones,
and aminoglycosides. Other eﬀective antibiotics against this micro-
organism include Imipenem, Azetronam, and novel quinolones such as
ciproﬂoxacin [7]. Polymyxin E and Carbapenems are the most eﬀective
antibiotics against MDR bacterial isolates [8]. The carbapenem re-
sistance mechanisms in MDR P. aeruginosa isolates include producing
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carbapenemases such as metallobetabalactamase, chromosomal ce-
phalosporinases, mutations in oprD gene, and overexpression of eﬄux
pumps [9]. The high production of chromosomal cephalosporinases
encoded by the ampC gene is one of the most important mechanisms of
drug resistance [10]. The ampC is involved in resistance to Aminope-
nicillins, Cephalosporins, Cephamycins, Carbapenems, and Mono-
bactams [11].
In addition to the antibiotic resistance mechanisms, the diverse
virulence factors of P. aeruginosa also participate in the development
and spread of the infection. The most important virulence factors of P.
aeruginosa include producing exoenzyme A, Type III secretion system
(T3SS) proteins, exotoxin U, exotoxin S, exotoxin T, exotoxin Y, elas-
tase, alkaline protease, and bioﬁlms [12]. The exotoxin S encoded by
the exoS gene is one of the most important virulence factors produced
by 40–60% of P. aeruginosa strains as well as is the most important
factor in spreading infection [13]. ExoS protein is transported by the
type 3 secretory system and is associated with antibiotic resistance
[13]. Furthermore, this protein modulates phagocytosis by phagocytes,
augments the invasion to nonphagocytic cells, induces programmed cell
death in epithelial cells, lymphocytes and ﬁbroblasts, and protects P.
aeruginosa from being killed by macrophages and PMNs. These eﬀects
are essential in the spread of the P. aeruginosa wound infections
[14,15].
This virulence factor is the most important contributor to the spread
of the infection in burn patients by protecting the bacterium from being
killed by macrophages and PMNs (polymorphonuclear). These drug
resistance genes and virulence factors render the treatment of P. aeru-
ginosa infections, especially those emerged from MDR strains, somehow
diﬃcult [9,16].
New strategies that have been used for treating MDR bacterial
strains include using nanoparticles, phase therapy, and medicinal
plants. Because of their potent antibacterial eﬀects and low cytotoxi-
city, medicinal plants are now widely employed to either prevent or
treat bacterial infections [17]. Thyme is an herb with anti-bacterial
eﬀects, and Carvacrol is one of its important active ingredients. Car-
vacrol permeates into the cell membrane, chelates membrane surface
cations, and consequently inhibits ATPase activity [18]. Carvacrol can
also regulate metabolic activities and gene and protein expressions
[19]. Cinnamon is another antibacterial agent inhibiting the growth of
a wide range of microorganisms such as Escherichia coli, Staphylococcus
aureus, Brucella spp., Klebsiella pneumoniae, Proteus spp., and Bacillus
cereus. Cinnamon is comprised of compounds such as Cinnamyl acetate,
Cinnamaldehyde, para-cimen, and para-cimol. Cinnamaldehyde is the
most important ingredient of cinnamon. The carbonic group of Cinna-
maldehyde binds and deactivates bacterial proteins and inhibits the
function of bacterial amino acid decarboxylase [20]. Furthermore,
several reports have indicated the ability of honey to inhibit the growth
of microorganisms [21]. Honey consists of several active ingredients
such as phenolic acids, ﬂavonoids, and peroxides which limit the
growth of most Gram-positive and negative bacteria [22]. In addition to
antibacterial properties, combinations of these extracts with honey
have shown anti-inﬂammatory properties. Carvacrol modulates mem-
brane structures, metabolic activities, gene expression, and protein
synthesis [19]. Honey stimulates the production of phenolic acid, ﬂa-
vonoids, peroxide and amylase [22]. As well, honey limits the growth of
microorganisms through aﬀecting osmotic properties of environment
[23]. Flavonoids derived from honey participate in wound healing
process by stimulating the immune system and cytogenesis [20,24]. On
the other hand, Cinnamaldehyde inhibits the early stages of bioﬁlm
formation which is under the control of the QS system [25]. Cinna-
maldehyde also limits the growth of P. aeruginosa and many other pa-
thogenic bacteria by disturbing electron transport chain [26]. Con-
sidering beneﬁcial properties of these compounds, they can be eﬀective
agents to overcome antibiotic resistance and promote wound healing
process. Therefore, this study aimed to investigate the inhibitory eﬀects
of Cinnamaldehyde, Carvacrol, and honey, alone and in combinations,
on the expressions of exoS and ampC antibiotic resistance genes in MDR
P. aeruginosa strains isolated from burn wound infections.
2. Materials and methods
2.1. Ethics statements
This work was approved by the ethics committee of Kashan
University of Medical Science; IR. KAUMS.NUHEPM.REC.1397.29.
2.2. Bacterial strains
Thirty-ﬁve P. aeruginosa isolates were recovered by consecutive
samplings from burn wound infections of patients admitted to the burn
ward of Besat hospital of Hamadan, Iran, during 2018.
2.3. Antibiotic susceptibility testing
Antibiotic susceptibility testing was performed using Kirby-Bauer
disk diﬀusion method, and MDR isolates were identiﬁed according to
the CLSI instructions [27] and based on the standardized international
terminology introduced by the Centers for Disease Control and Pre-
vention (CDC) in 2011 [28]. The MDR was deﬁned as non-susceptibility
to at least one antibiotic in ≥3 antimicrobial categories. E. coli ATCC
25922 and P. aeruginosa ATCC PAO1 were used as reference strains. All
the experiments were repeated three times.
The susceptibility proﬁles were determined for Ceftazidime (30 μg),
Ciproﬂoxacin (5 μg), Imipenem (10 μg), Meropenem (10 μg),
Piperacillin-tazobactam (30 μg), Colistin (10 μg), Aztreonam (30 μg),
Amikacin (30 μg), Cefepime (3030 μg), Ticarcillin-clavulanic acid (75/
10 μg), Meropenem (10 μg), and Gentamicin (30 μg) (MAST, Bootle,
Merseyside, UK). The Muller Hinton broth dilution method was used to
conﬁrm Imipenem-resistant strains. The MIC for Imipenem was de-
termined using microbroth dilution method according to the CLSI
standards [29].
2.4. Active components
The Cinnamaldehyde and Carvacrol were purchased from Sigma-
Aldrich. The natural honey used in this study was provided by
Damavand district, Iran. Damavand is situated about 60 km to the east
of Tehran and has mountainous geography and dry-cool weather.
2.5. MIC determination
The MICs of Cinnamaldehyde, Carvacrol, and honey were de-
termined using the broth microdilution method as described by the
CLSI standards [30]. In brief, several colonies of the isolates were in-
oculated into the brain heart infusion (BHI) medium (HiMedia, India)
and incubated at 37 °C for 24 h. Then, a suspension with half McFarland
turbidity was prepared in sterile BHI broth (absorbance of 0.08–0.1 at
625 nm). A suspension containing 1.5 × 105 CFU/mL bacteria was
prepared, and then 100 μL of the suspension was transferred into mi-
crotiter plate wells. The bacterial suspensions were ﬁnally treated with
100 μL of various concentrations of each compound diluted in BHI.
Positive (BHI and the bacterial suspension), and negative (BHI without
the bacterial suspension) controls were also used. The microtiter plates
were incubated at 37 °C for 24 h without shaking. Finally, the MIC was
determined as the lowest concentration that inhibited the visible
growth of the bacteria.
2.5.1. Checkerboard titration
Combinations of each of Cinnamaldehyde and Carvacrol with honey
were tested via the checkerboard titration method. The MIC con-
centration of the antimicrobial agents ranged from 1/16 to 8. The
fractional inhibitory concentration (FIC) index was calculated using the
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following equation:
FICindexWhere MIC A is the MIC of the compound A alone, and MIC
A/B/C is the MIC of the compound A in combination. Likewise, MIC B
and MIC B/A/C are the MICs of compound B alone and in combination,
respectively. In the same way, MIC C and MIC C/A/B represent the
MICs of compound C alone and in combination, respectively. Synergy,
additivity, indiﬀerence, and antagonism were deﬁned as FIC values of
≤0.5, 0.5–1, 1–4, and> 4 respectively [31].
Furthermore, the antibacterial eﬀect of the sub-MIC concentration
(1/4 MIC) of the triple combination (Cinnamaldehyde, Carvacrol, and
honey) was assessed on bacterial suspensions containing 105 CFU/mL
cells in the BHI medium. The combination of the medium and bacterial
suspension without the triple compound was used as the negative
control. The same test was performed for Imipenem as the control an-
tibiotic. The tubes were incubated at 37 °C for 24 h.
2.6. Gene expression analysis by Real-Time reverse transcription PCR
Real-Time PCR technique was used to investigate the gene expres-
sions of ampC and exoS. Six samples including 1 Imipenem-susceptible
and 4 Imipenem-resistant strains along with P. aeruginosa ATCC PAO1
(i.e. positive control) were selected to assess gene expression.
2.6.1. RNA extraction and cDNA synthesis
Bacterial RNA was extracted using RNX-Plus kit (SinaColon, Iran)
based on the manufacturer's directions. The extracted RNA was quan-
tiﬁed using a NanoDrop Spectrophotometer. The ratio of absorbance at
260–280 nm was used to estimate the purity of the extracted RNA. A
ratio of ~2.0 was considered as “pure” RNA. The quality of the ex-
tracted RNA was also assessed by electrophoresis on 1.5% agarose gel at
100 V for 40 min. Genomic DNA was removed by RNase-free DNase I
(RNA biotechnology, Iran) according to the manufacturer's directions,
and cDNA was synthesized using cDNA Synthesis Kit (RNA bio-
technology, Iran) using 1 μg of the extracted RNA. After that, 5 ng of the
synthesized cDNA was used for determining gene expression using
speciﬁc primers (Table 1).
Real-Time PCR was performed by ABI-X Plus system (Advanced
Biosystems, Foster, California, USA) using SYBR Green kit (ABI. USA).
Temperature conditions included an initial activation phase (95 °C for
15 min) followed by 35 cycles at 95 °C for 30 s and 60 °C for 60 s. The
rpoD gene that encodes the sigma factor of RNA polymerase was used as
the internal (or endogenous) control. Finally, the cycle threshold (Ct)
was used to calculate mRNA expression as a mean fold change by the
ΔΔCT method. All the experiments were performed in triplicate.
2.7. Statistical analysis
The Kruskal Wallis and Mann-Whitney U tests were used to compare
the MIC values in diﬀerent groups. Also, One-Sample student t-test was
used to compare the expression levels of the genes in diﬀerent groups.
The P-value<0.05 was considered as statistically signiﬁcant.
3. Results
3.1. Bacterial strains
Thirty-ﬁve P. aeruginosa isolates were recovered from clinical sam-
ples. Overall, 55% and 45% of the patients with burn infections were
males and females, respectively.
3.2. Antibiotic susceptibility testing and MIC of imipenem
As shown in Table 2, no resistance was observed against colistin.
Also, the highest resistance was reported to Ticarcillin-clavulanic acid
with frequency 26 (74.3%). Among 35 P. aeruginosa isolates, 22 were
MDR strains. According to the obtained MICs, all the isolates were re-
sistant to Imipenem. The MICs of Imipenem ranged from 8 to 13 μg/mL.
3.3. MICs of Cinnamaldehyde, Carvacrol, and honey
The MIC values of Cinnamaldehyde, Carvacrol, and honey have
been shown in Table 3. The average MICs of Cinnamaldehyde, Carva-
crol, and honey were obtained as 0.17, 0.17, and 114.2 μg/mL, re-
spectively. The MIC of the triple combination of Cinnamaldehyde,
Carvacrol, and honey was 0.49 μg/mL.
3.4. Synergistic eﬀects of Cinnamaldehyde, Carvacrol, and honey
According to the results of FIC analysis, the synergistic eﬀect of the
three assessed agents was observed against 77.3% of the isolates. The
FIC values of the combinations of each of Cinnamaldehyde and
Carvacrol with honey against MDR and non-MDR P. aeruginosa isolates
have been shown in Fig. 1. No signiﬁcant diﬀerences were found
comparing the average MIC values of the combinations of Cinna-
maldehyde and Carvacrol with honey compared to Cinnamaldehyde
and Carvacrol alone. However, the MICs of the combinations were
signiﬁcantly diﬀerent from that of honey alone (Fig. 2, P < 0.0001).
Table 1
The primer sequences used in this study.
Target gene Sequence primer (5'➔3′) Amplication size (bp) Annealing temperature (°C) REF
rpoD-F
rpoD-R
GTCCTCAGCGGCTATATC
CTCGTCGTCCTTCTCTTT
108 53.8 This Study
exoS-F
exoS-R
GAAATCACCGACCAGTTG
CGATACTCTGCTGACCTC
84 53.5 This Study
ampC-F
ampC-R
GAGAACCGCATTACTTCAG
CATCTTGTCCTGGGTCAG
143 53.5 This Study
Table 2
Antibiotic susceptibility pattern of P. aeruginosa isolates.
Antibiotics Susceptible (N,
%)
Intermediate (N,
%)
Resistant (N,
%)
Colistin 35 (100) 0 0
Cefepime 11 (31.4) 10 (28.6) 14 (40)
Aztreonam 8 (23) 12 (34.3) 15 (42.7)
Amikacin 13 (37.1) 3 (8.57) 19 (54.3)
Piperacillin-
Tazobactam
12 (34.3) 8 (23) 15 (42.7)
Ciproﬂoxacin 9 (25.7) 12 (34.3) 14 (40)
Ceftazidime 13 (37.1) 2 (5.75) 20 (57.1)
Imipenem 15 (42.7) 7 (20) 13 (37.1)
Gentamicin 16 (45.7) 2 (5.75) 17 (48.57)
Meropenem 12 (34.3) 7 (20) 16 (45.7)
Ticarcillin-clavulanic
acid
7 (20) 2 (5.7) 26 (74.3)
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3.5. The eﬀect of sub-MIC of Cinnamaldehyde, Carvacrol and honey
combination on gene expressions of exoS and ampC
Six P. aeruginosa isolates were chosen to assess gene expressions of
exoS and ampC by Real-Time PCR. The results showed signiﬁcant re-
ductions in the expressions of exoS (−6.12 folds) and ampC (−2.85)
genes (P < 0.0001). The expressions of exoS (Fig. 3) and ampC (Fig. 4)
in bacteria treated with sub-MIC (1/4 MIC) of Imipenem decreased by
3.31 and 4.45 folds respectively. In this study, the housekeeping rpoD
gene was used as internal control.
4. Discussion
The incidence of MDR P. aeruginosa has been on a rise in recent
years [32]. In this regard, nosocomial infections caused by MDR P.
aeruginosa strains are important in burn patients. Due to the importance
of Imipenem in the treatment of such infections, we here investigated
the anti-bacterial eﬀects of Cinnamaldehyde, Carvacrol, and honey on
Imipenem-resistant P. aeruginosa strains. Most of Imipenem-resistant P.
aeruginosa strains express ampC gene which encodes beta-lactamase.
This enzyme, in turn, mediates the hydrolysis of a broad-spectrum of
antibiotics conferring selective antibiotic resistance. The exoS and exoS
genes of P. aeruginosa impart important roles in the proliferation and
colonization of epithelial cells and the induction of systemic infection in
burn patients [33]. Regarding the high rate of drug-resistant P. aeru-
ginosa isolates, there is a necessity to search for novel drugs with better
accessibility, fewer side eﬀects, and lower costs.
In the present study, the MIC of Carvacrol ranged from 0.3 to
0.01 μg/mL. In a study conducted by Xujing et al., in 2008, the anti-
bacterial eﬀects of Carvacrol in combination with Thymol were eval-
uated against E. coli using the Time-Kill method. In the recent report,
the bacterium did not grow at the concentration of 800 μg/mL of this
compound after 6 h of incubation at 37 °C. In another study conducted
by Mahboubi et al. in 2016, the mean MIC values of Carvacrol and
Khuzestanica savory (Carvacrol comprises 94% of the savory content)
against E. coli were reported as 0.08 ± 0.14 and 0.04–0.09 μg/mL
respectively. In comparison, the inhibitory concentration of Carvacrol
reported in the recent study was similar to ours conﬁrming the anti-
bacterial eﬀects of this agent.
According to our results, the MIC values of Carvacrol ranged from
0.01 to 0.3 μg/mL which were 100 times lower than the MICs of
Imipenem (8–13 μg/mL). Our results also showed the synergistic anti-
bacterial eﬀects of Carvacrol against 77% of the isolates. The sy-
nergistic eﬀect of Carvacrol may be explained by a variety of its anti-
bacterial actions such as increasing cytoplasmic membrane perme-
ability, increasing hydrostatic pressure, and inhibiting nucleic acid and
protein synthesis. Carvacrol enhances membrane permeability through
modulating ATP level in bacteria and subsequently activates a series of
reactions leading to a halt in bacterial growth. Meanwhile, the anti-
bacterial eﬀects of Carvacrol were augmented in combinations with the
two other compounds; Cinnamaldehyde and honey. Various studies
have indicated that honey has broad-spectrum antimicrobial activities
against Gram-positive and negative bacteria such as P. aeruginosa, K.
pneumonia, E. coli, Staphylococcus spp., etc. Therefore, honey can be
used as an alternative to antibiotic therapy [22].
In the present study, the MICs of honey ranged from 62.5 to 250 μg/
mL. In contrast to our study, Ghotaslou et al. reported that MICs of
three types of Iranian honeys (i.e. Kleiber, Chamomile, and Sahand)
against P. aeruginosa ranged from 6.25 to 25 w/v [34] which were
lower than the MICs obtained in our study. This may be because all the
P. aeruginosa isolates in our study were MDR strains partly explaining
the higher MICs in our study. Also, in another study conducted by
Hammond et al. in the United States in 2106, the antibacterial activity
of natural American honey was compared with that of synthetic honey
against 11 pathogens including two P. aeruginosa isolates. In the recent
study, the MIC of the natural honey against P. aeruginosa was 15.7% w/
v. This was while the synthetic honey did not show any speciﬁc anti-
bacterial eﬀect up to 50% w/v concentration [35]. The variable MICs of
various honeys in diﬀerent studies can be related to diﬀerent honey
types and clinical isolates. In another study conducted by Sanla et al. in
2012, the MIC of Cinnamaldehyde against Listeria monocytogenes was
reported as 6.5 mg [36]. The diﬀerent MICs in our study and that of
Sanla et al. can be attributed to the types of studied microorganisms.
Furthermore, Shen et al. reported the MIC of Cinnamaldehyde against
E. coli as 0.31 mg which was similar to our results.
Antibiotics used to treat pseudomonas infections often aﬀect cell
wall permeability or protein synthesis. The beta-lactam antibiotics in
combination with aminoglycosides are usually recommended as the
ﬁrst-line antibiotic therapy for pseudomonas infections as they aﬀect
Table 3
The MIC of essential oil with honey for used isolates.
The compound used Minimum-Maximum (μg/mL) Mean ± SD
Hony 62.5–250 114.2 ± 35.5
Carvacrol 0.01–0.6 0.17 ± 0.31
Cinnamaldehyde 0.01–1.6 0.17 ± 0.14
Fig. 1. Comparision of MDR and Non-MDR isolates based on FIC values. This graph shows that the compound has a eﬀect synergistic on both MDR and Non MDR
isolates. FICi: Fractional inhibitory concentration index; MDR: Multiple drug resistance; Non MDR: Non -Multiple drug resistance.
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both cell wall permeability and protein synthesis. As well, Carvacrol
used in this study increases bacterial cell wall permeability and inter-
feres with DNA and RNA synthesis. In addition, Carvacrol inhibits in-
ﬂammation at the burn site by inhibiting prostaglandins E2, F1 and F2.
Cinnamaldehyde, on the other hand, exudes cytotoxic eﬀects against
many pathogens by preventing dicarboxylic acid activity and protein
synthesis [37,38]. Besides, hydrogen peroxide and other similar en-
zymes contribute to the antibacterial actions of honey [39–41]. Ac-
cordingly, the anti-bacterial eﬀects of Carvacrol, Cinnamaldehyde, and
honey can be synergistically augmented by exploiting a combination of
the above-mentioned mechanisms. Among the three agents, the anti-
bacterial eﬀects of honey were more profoundly augmented in the triple
Fig. 2. The FICi values of tested combination compared to each of univalent. As shown in the graph, Cinnamaldehyde and Carvacrol are eﬀective in combination, but
Honey is not eﬀective in combination state.
Fig. 3. The compound caused more reduction in exoS gene expression level compared to Imipenem antibiotic in all the isolates.
Fig. 4. The compound caused more reduction in ampC gene expression level compared to Imipenem antibiotic in all the isolates.
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combination. Similar to our study, Cinnamaldehyde, thymol, and Car-
vacrol showed a synergistic eﬀect against Salmonella typhimurium [42].
One advantage of the present study was investigating the expres-
sions of virulence genes to conﬁrm anti-bacterial activities of the as-
sessed compounds. Besides, routine methods for assessing anti-bacterial
activity (i.e. MIC determination, disk diﬀusion, and RT-PCR) [43], we
here for the ﬁrst time used Real-Time quantitative RT-PCR to determine
gene expressions of virulence factors. In a study by Jalalvandi et al.
(2015), treatment with Carvacrol extracted from Satureja khuzestanica
decreased the expressions of mexR and mexA drug-resistance genes in P.
aeruginosa [44]. In parallel, we here for the ﬁrst time showed that
Carvacrol and Cinnamaldehyde in combination with honey decreased
the expressions of two other virulence genes (i.e. ExoS and ampC) in P.
aeruginosa. Likewise, the triple combination of Carvacrol, Cinna-
maldehyde, and honey signiﬁcantly decreased the expressions of both
mentioned genes; however, these reductions were not signiﬁcantly
diﬀerent compared with Imipenem-treated bacteria. Interestingly, all
the isolates in this study were resistant to Imipenem which is the main
selective antibiotic used in burn infections caused by P. aeruginosa.
In this study, we showed that the MIC of the combination of
Carvacrol, Cinnamaldehyde, and honey was 100 times lower compared
to that of Imipenem. Considering this lower MIC and its safety proﬁle,
this combination can provide an appropriate alternative to treat bac-
terial infections. The main limitation of this study was that we did not
address the cytotoxicity of this compound against human cell lines.
5. Conclusions
The combination of Cinnamaldehyde, and Carvacrol with honey
showed a higher antibacterial eﬀect than Imipenem. Of course, with
more isolates this should be conﬁrmed.
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